APG Asset Management N.V. trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 9.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 335,778 shares of the company's stock after selling 34,418 shares during the period. APG Asset Management N.V. owned approximately 0.14% of Cardinal Health worth $42,826,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Principal Financial Group Inc. raised its position in shares of Cardinal Health by 5.3% in the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock valued at $43,510,000 after acquiring an additional 15,956 shares during the period. Kingswood Wealth Advisors LLC raised its position in shares of Cardinal Health by 17.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock valued at $429,000 after acquiring an additional 457 shares during the period. Assenagon Asset Management S.A. raised its holdings in Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after buying an additional 2,694 shares during the period. Golden State Wealth Management LLC raised its holdings in Cardinal Health by 569.5% during the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock worth $54,000 after buying an additional 336 shares during the period. Finally, North Capital Inc. acquired a new stake in Cardinal Health during the 1st quarter worth approximately $83,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CAH has been the topic of several research analyst reports. Wells Fargo & Company restated an "overweight" rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Leerink Partners dropped their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a report on Tuesday, August 12th. Bank of America raised their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Robert W. Baird raised their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $165.93.
Check Out Our Latest Research Report on CAH
Insider Buying and Selling
In related news, insider Jessica L. Mayer sold 38,078 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider owned 48,457 shares of the company's stock, valued at $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jason M. Hollar sold 35,901 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the transaction, the chief executive officer directly owned 200,000 shares of the company's stock, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 in the last 90 days. 0.09% of the stock is currently owned by corporate insiders.
Cardinal Health Stock Up 0.2%
Shares of NYSE:CAH traded up $0.33 during midday trading on Thursday, hitting $149.57. The stock had a trading volume of 2,877,072 shares, compared to its average volume of 2,420,158. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44. The business's 50-day simple moving average is $158.02 and its 200-day simple moving average is $145.75. The company has a market cap of $35.72 billion, a P/E ratio of 23.19, a PEG ratio of 1.25 and a beta of 0.67.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health's revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's payout ratio is presently 31.63%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report